Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11)-Reference-Cited by-同舟云学术

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11)

Published:2013-09-19 Issue:23 Volume:119 Page:4180-4187
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Fangusaro Jason¹,Gururangan Sridharan²,Poussaint Tina Young³,McLendon Roger E.²,Onar-Thomas Arzu⁴,Warren Katherine E.⁵,Wu Shengjie⁴,Packer Roger J.⁶,Banerjee Anu⁷,Gilbertson Richard J.⁴,Jakacki Regina⁸,Gajjar Amar⁴,Goldman Stewart¹,Pollack Ian F.⁸,Friedman Henry S.²,Boyett James M.⁹,Kun Larry E.⁴,Fouladi Maryam¹⁰

Affiliation:

1. Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago Illinois

2. Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham North Carolina

3. Boston Children's Hospital; Boston Massachusetts

4. St. Jude Children's Research Hospital; Memphis Tennessee

5. National Cancer Institute; Bethesda Maryland

6. Children's National Medical Center; Washington DC

7. University of California at San Francisco; San Francisco California

8. Children's Hospital of Pittsburgh; Pittsburgh Pennsylvania

9. Operations and Biostatistics Center for the Pediatric Brain Tumor Consortium; St. Jude Children's Research Hospital; Memphis Tennessee

10. Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

Publisher